Fidasimtamab (IBI-315; BH2950) is a recombinant human IgG1 bispecific antibody that targets, binds and inhibits both HER2 and PD-1 and their downstream signalling pathways, and links PD-1 expressing T cells to HER2 expressing tumour cells. Fidasimtamab has potential immunosuppressive and antitumor activity.
Form:Liquid
规格
别名
非达辛他单抗
规格或纯度
≥95%
英文名称
Fidasimtamab
生化机理
Fidasimtamab(IBI-315;BH2950)是一种重组人IgG1双特异性抗体,可靶向、结合并抑制HER2和PD-1及其下游信号通路,并将PD-1表达的T细胞与HER2表达的肿瘤细胞联系起来。Fidasimtamab ha